Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma
- 1 December 1979
- journal article
- case report
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 95 (3) , 281-286
- https://doi.org/10.1007/bf00410649
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- PHOTODEGRADATION OF DACARBAZINEThe Lancet, 1978
- Hepatic-Vein Thrombosis After Chemotherapy for HistiocytomaAnnals of Internal Medicine, 1978
- Leukemia Chemotherapy and Centrilobular Hepatic NecrosisAnnals of Internal Medicine, 1977
- Veno-Occlusive Disease of the Liver After Chemotherapy of Acute LeukemiaAnnals of Internal Medicine, 1976
- Mechanism of action and pharmacology studies with DTIC (NSC-45388).1976
- Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.1976
- Chemotherapy of malignant melanomaCancer, 1972
- Combination Phase 1 -II Study of Imidazole Carboxamide (NCS 45388)Oncology, 1972
- Studies of the mechanism of action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4(5)-carboxamide in Bacillus subtilisBiochemical Pharmacology, 1970
- N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.1970